Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
As of 12 August 2026, Releaf has the highest Trustpilot score, 4.8 from 9,598 reviews. Curaleaf received an overall CQC rating of ‘Good’, Alternaleaf advertises appointments for £29, while Mamedica's £200 Access Scheme is designed to potentially reduce long-term clinic costs. The right clinic for you will depend on what you value most from a clinic, but comparing the full treatment experience, rather than a single headline figure, is essential.
The UK government has launched a new review into medical cannabis laws, asking patients, families, and healthcare professionals to share their experiences. With Releaf patients already contributing to research efforts with our survey results due for release in November, this marks a crucial step in shaping access to cannabis-based medicines.
October is Menopause Awareness Month, and PAUSE Live - the UK’s largest menopause and women’s health event - is coming back for its third edition. This year, Releaf are proud to be attending the event for the second year in a row. Read on to learn more about this year’s event, our presence, and the potential of medical cannabis for menopause and women’s health symptoms.
The menopause is an unfortunate, yet inevitable, reality for every person born with a womb. Sleepless and restless nights, joint and bone aches, mood swings, temperature fluctuations, and that all-encompassing, nail-biting anxiety accompany this hormonal change for many, making daily life not just difficult - sometimes, they make life feel down-right gruelling.
The first randomised controlled trial of cannabis for migraine compared THC, CBD, THC with CBD, and placebo. Results showed that THC and CBD combined offered the strongest benefits, while THC alone provided partial relief and CBD alone had a limited effect. We explain the findings, what they mean for patients, safety considerations, and how this all affects medical cannabis access in the UK.
